Search Ontology:
ChEBI
alogliptin benzoate
- Term ID
- CHEBI:72324
- Synonyms
-
- (3R)-1-[3-(2-cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl]piperidin-3-aminium benzoate
- 2-({6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl}methyl)benzonitrile benzoate
- 6-((3R)-3-aminopiperidin-1-yl)-1-(2-cyanobenzyl)-3-methylpyrimidin-2,4(1H,3H)-dione monobenzoate
- alogliptin monobenzoate
- Nesina
- SYR 322
- SYR-322
- Definition
- A benzoate salt obtained by combining equimolar amounts of alogliptin and benzoic acid. Used for treatment of type 2 diabetes.
- References
-
- CAS:850649-62-6
- KEGG:D06553
- PMID:18499100
- PMID:19427871
- PMID:19455266
- PMID:20883057
- PMID:21233588
- PMID:21431099
- PMID:22296609
- PMID:22512582
- Patent:EP1586571
- Patent:EP1970063
- Patent:US2007066635
- Patent:WO2010109468
- Patent:WO2011141903
- Reaxys:12413070
- Wikipedia:Alogliptin
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_part
-
- has_role
-
Phenotype
Phenotype resulting from alogliptin benzoate
Phenotype where environments contain alogliptin benzoate
Phenotype modified by environments containing alogliptin benzoate
Human Disease / Model Data